These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23649327)

  • 1. Alteration of tumor microenvironment for improved delivery and intratumor distribution of nanocarriers.
    Ishida T; Kiwada H
    Biol Pharm Bull; 2013; 36(5):692-7. PubMed ID: 23649327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
    Alshememry AK; El-Tokhy SS; Unsworth LD
    Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-targeting glycol chitosan nanocarriers: overcoming the challenges posed by chemotherapeutics.
    Choi Y; Lim S; Yoon HY; Kim BS; Kwon IC; Kim K
    Expert Opin Drug Deliv; 2019 Aug; 16(8):835-846. PubMed ID: 31343904
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent advances in drug delivery systems for enhancing drug penetration into tumors.
    He B; Sui X; Yu B; Wang S; Shen Y; Cong H
    Drug Deliv; 2020 Dec; 27(1):1474-1490. PubMed ID: 33100061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
    Muntimadugu E; Kommineni N; Khan W
    Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocarriers to solid tumors: considerations on tumor penetration and exposure of tumor cells to therapeutic agents.
    Bhagat M; Halligan S; Sofou S
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1306-16. PubMed ID: 22201591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic nanocarriers for cancer drug delivery.
    López-Dávila V; Seifalian AM; Loizidou M
    Curr Opin Pharmacol; 2012 Aug; 12(4):414-9. PubMed ID: 22465543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
    Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
    J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring Therapeutic Potential of Nanocarrier Systems Against Breast Cancer.
    Kumar L; Baldi A; Verma S; Utreja P
    Pharm Nanotechnol; 2018; 6(2):94-110. PubMed ID: 29866028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Application of Stimuli-responsive Nanocarriers for Targeted Drug Delivery.
    Zhou M; Wen K; Bi Y; Lu H; Chen J; Hu Y; Chai Z
    Curr Top Med Chem; 2017; 17(20):2319-2334. PubMed ID: 28240179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
    Danhier F; Feron O; Préat V
    J Control Release; 2010 Dec; 148(2):135-46. PubMed ID: 20797419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics.
    Huang D; He B; Mi P
    Biomater Sci; 2019 Oct; 7(10):3942-3960. PubMed ID: 31414096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites.
    Cao J; Huang D; Peppas NA
    Adv Drug Deliv Rev; 2020 Dec; 167():170-188. PubMed ID: 32622022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
    Koning GA; Krijger GC
    Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered strategies to enhance tumor penetration of drug-loaded nanoparticles.
    Souri M; Soltani M; Moradi Kashkooli F; Kiani Shahvandi M
    J Control Release; 2022 Jan; 341():227-246. PubMed ID: 34822909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral drug delivery with nanoparticulate carriers.
    Holback H; Yeo Y
    Pharm Res; 2011 Aug; 28(8):1819-30. PubMed ID: 21213021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of cisplatin efficacy by lipid-CaO
    He C; Zhang X; Yan R; Zhao P; Chen Y; Li M; Chen C; Fan T; Lu Y; Wang C; Wu F; Lee RJ; Yang T; Xiang G
    Biomater Sci; 2019 Oct; 7(10):4260-4272. PubMed ID: 31402373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment.
    Martin JD; Panagi M; Wang C; Khan TT; Martin MR; Voutouri C; Toh K; Papageorgis P; Mpekris F; Polydorou C; Ishii G; Takahashi S; Gotohda N; Suzuki T; Wilhelm ME; Melo VA; Quader S; Norimatsu J; Lanning RM; Kojima M; Stuber MD; Stylianopoulos T; Kataoka K; Cabral H
    ACS Nano; 2019 Jun; 13(6):6396-6408. PubMed ID: 31187975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-enabled delivery of diverse payloads across complex biological barriers.
    Ross KA; Brenza TM; Binnebose AM; Phanse Y; Kanthasamy AG; Gendelman HE; Salem AK; Bartholomay LC; Bellaire BH; Narasimhan B
    J Control Release; 2015 Dec; 219():548-559. PubMed ID: 26315817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery strategies based on multifunctional nanocarriers for cancer therapy.
    Chen H; Zhao Y; Wang H; Nie G; Nan K
    Curr Drug Metab; 2012 Oct; 13(8):1087-96. PubMed ID: 22380013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.